India’s Glenmark is rolling all of the new molecular entities (NMEs) in its pipeline into a separate U.S. company in an effort to speed the programs to market. Glenmark says all its preclinical and ...

The Biotechnology Industry Organization (BIO) today announces the initial selection of presenting companies for the 3rd Annual , September 12-13 at the Grand Hyatt in Mumbai, India. Through company ...

India is a global pharmacy powerhouse, but not yet a deep science leader. The gap between talent and trust may be pushing ...

HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...

Ahmedabad: While the state is often termed the ‘pharmacy of India' due to a mature ecosystem of pharmaceuticals in terms of ...

Ahmedabad-based Concord Biotech has sold a 20% stake in itself to the private equity fund Quadria Capital for about $75 million with the investment valuing the bulk-drug maker at about $373 million, ...

BENGALURU, Feb 18 (Reuters) - India's Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vaccine, COVAXIN, in more than 40 countries, the company told Reuters ...

After India became an independent nation in 1947, Prime Minister Jawaharlal Nehru's socialist vision to improve the quality of life for the masses identified a central role for science and technology.